Lilly Doubles Down on Insilico's AI Medicines, Bets Up to $2.75B
Eli Lilly is expanding its partnership with Insilico Medicine, investing $115 million upfront with potential milestones up to $2.75 billion to use AI-powered drug discovery platforms for oral drugs against various diseases.
Key Points
- Lilly commits $115 million upfront with potential milestones up to $2.75 billion
- Partnership uses Insilico's AI platforms for oral drug development
- Builds on Lilly's existing AI partnership with NVIDIA for drug discovery
- Represents one of the largest pharmaceutical AI deals to date
Full Details
Eli Lilly is significantly expanding its partnership with Insilico Medicine, committing $115 million upfront with potential milestone payments reaching up to $2.75 billion. The deal leverages Insilico's machine learning platforms for oral drug development against a variety of diseases. The two companies will collaborate on multiple R&D programs centered on targets of Lilly's choosing, utilizing Insilico's AI platforms. This agreement builds on Lilly's broader AI push, including a partnership last year with NVIDIA to build a supercomputer for drug discovery optimization. Andrew Adams, Lilly's group vice president of Molecule Discovery, called Insilico's AI-enabled engine 'a powerful complement to Lilly's deep expertise in clinical development.' The partnership represents one of the largest pharmaceutical AI deals to date.
Why It Matters
The massive investment signals AI drug discovery is moving from experimental to mainstream, potentially accelerating the entire pharmaceutical development timeline and reducing costs.
Get stories like this delivered daily
AI-curated news, personalized to your interests. Zero noise.
Start 7-Day Free Trial →More in Artificial Intelligence
California to Impose New AI Regulations in Defiance of Trump Call
Governor Gavin Newsom signed an executive order giving California four months to develop AI policies prioritizing public safety, requiring companies seeking state contracts to demonstrate safeguards against child sexual abuse material and violent pornography distribution.
Eli Lilly Doubles Down on Insilico Medicine AI Partnership, Bets Up to $2.75 Billion
Eli Lilly is expanding its partnership with Insilico Medicine, committing $115 million upfront and up to $2.75 billion in total to use the biotech's AI-powered machine learning platforms for developing oral drugs against various diseases.
Mass Flight Disruptions Strand Thousands Across Asia and Türkiye
Thousands of passengers were stranded today as widespread flight cancellations and delays affected major airports across Thailand, Japan, Hong Kong, China, Malaysia, and Türkiye, with 307 cancellations and 2,797 delays recorded across multiple hubs.
Israel Deploys AI Platform to Target Iranian Leaders Amid Regional Tensions
Israel has developed a new AI platform enabling lethal targeting of Iranian leaders, as part of escalating tensions in the Middle East, according to the Washington Post AI & Tech Brief.